Device Trade Groups Offer Lukewarm Comments On Pre-RFD Draft
Executive Summary
BIO and AdvaMed offered multiple concerns about a January US FDA draft guidance formalizing the pre-RFD process, including that the timeline is too long and that the recommended information may not land manufacturers a center designation.